Keyphrases
Neuroblastoma
100%
Synergize
100%
Cyclophosphamide
100%
Tumor Lysate
100%
Immune-modulating Effects
100%
CpG ODN
71%
T-cell Mediated
57%
Anti-neuroblastoma
28%
Tumor Cell Lysate
28%
Murine Model
14%
Antitumor Activity
14%
Allogeneic
14%
Tumor
14%
High Risk
14%
CD8+ T Cells
14%
Standard of Care
14%
Antitumor
14%
Tumor Site
14%
Effector Cells
14%
Antitumor Immune Response
14%
Immune Therapy
14%
Disseminated Infection
14%
Neural Crest
14%
Pediatric Cancer
14%
New Combination
14%
Combination of Therapies
14%
Lymphopenia
14%
Aggressive Treatment
14%
Lymphodepletion
14%
Subcutaneous Tumor
14%
Murine Tumor Model
14%
Clinical Considerations
14%
TLR9 Agonist
14%
Dendritic Cell Homeostasis
14%
Medicine and Dentistry
Neoplasm
100%
Immunity
100%
Cyclophosphamide
100%
Ganglioneuroblastoma
100%
CpG Oligodeoxynucleotide
55%
T Cell
44%
Tumor Cell
22%
Homeostasis
11%
Immune Response
11%
Neural Crest
11%
Tumor Model
11%
Antineoplastic Activity
11%
Lymphocytopenia
11%
Disseminated Disease
11%
Toll Like Receptor 9
11%
Pediatric Cancer
11%
Cytotoxic T-Cell
11%
Immunotherapy
11%
Dendritic Cell
11%